FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/05/2026
Back to search
Official data from USPTO
ORIFARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ORIFARM
ST13
US500000079370271Class
3, 5, 10, 35
Filing
79370271
Registration
7885422
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/06/2026
Trademark type
Word
Nice classes
3, 5, 10, 35
Filing date
01/27/2023
Registration date
08/12/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2025
Last transaction
03/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
84
Owner location
DK
Examiner
SULLIVAN, JOHN C
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Orifarm Generics A/S
Representatives
Meichelle R. MacGregor Cowan, Liebowitz & Latman, P.C.
Technical classification
Nice Classes
Class 3Class 5Class 10Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Non-medicated cosmetics and toiletry preparationsperfumery; essential oils; the foregoing excluding dental and other oral health care products
Class 5
Pharmaceutical preparations and chemical preparations for medical and veterinary purposesfor the treatment of metabolic and digestive conditionshematopoietic and circulatory conditionscardiac health conditionsdermatological conditionsurogenital conditionssex hormonal conditionssystemic hormonal conditionsinfectious diseasesantineoplastic and immunomodulatory conditionsmusculoskeletal health conditionsneurological conditionsparasitological conditionsrespiratory conditionsocular and auditory health conditionsallergens-related conditionshyperkalemiahyperphosphatemiacalcium metabolic imbalancesin the nature of pharmaceutical and medical preparations containing vitaminsmineralsantidotesiron chelating agentscontrast agents for the treatment of the aforementioned conditions; the foregoing excluding dental and other oral health care products
Class 10
Surgical apparatus and instruments; medical and veterinary apparatus and instruments for surgical use; medical and veterinary apparatus and instruments for therapeutic usetherapeutic equipment and devices for treating respiratorymetabolic and cardiovascular diseases in the nature of coldscoughingnasal congestionsore throatear congestionsinus congestionsinus inflammationinflammatory eye diseases; artificial limbs and eyes; orthopedic articlescushionssupportspaddingbandagesbracesfootwearhosierysolesbeltswalkers; suture materials; therapeutic articles and aids adapted for persons with disabilitiescompression wraps; massage apparatus; devices and articles for nursing infantsbottles; devices and articles for sexual activitysex toys; the foregoing excluding dental equipment and other oral health care products
Class 35
Retail and wholesale store services featuring non-medicated cosmetics and toiletriesperfumeryessential oilspharmaceuticalmedical and veterinary preparationssanitary preparations for medical purposesdietetic foods and preparations adapted for medical or veterinary usefoodstuffs for infantsdietary supplements for humans and animalsvitamins and vitamin preparationsmedical plastersmedical dressingssurgicalmedicalveterinary apparatus and instrumentsartificial limbs and eyesorthopedic articlessuture materialstherapeutic articles and aids adapted for persons with disabilitiesmassage apparatusdevices and articles for nursing infantsdevices and articles for sexual activity; the foregoing excluding dental equipment and other health care products
Publications
History of USPTO decisions and trademark events.
43 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/18/2026
FIMP
FINAL DISPOSITION PROCESSED
02/17/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/20/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/08/2025
APET
ASSIGNED TO PETITION STAFF
07/07/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/12/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/23/2024
RFNP
REFUSAL PROCESSED BY IB
09/21/2024
CNRT
NON-FINAL ACTION WRITTEN
08/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/30/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/30/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/30/2024
RFNP
REFUSAL PROCESSED BY IB
02/27/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/31/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/19/2024
GNRT
NON-FINAL ACTION E-MAILED
01/19/2024
CNRT
NON-FINAL ACTION WRITTEN
01/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2024
RFNT
REFUSAL PROCESSED BY IB
11/22/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/30/2023
RFRR
REFUSAL PROCESSED BY MPU
10/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2023
CNRT
NON-FINAL ACTION WRITTEN
10/26/2023
DOCK
ASSIGNED TO EXAMINER
10/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/25/2023
Continuous trademark protection
Get notified about every new filing that threatens ORIFARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.